Previous Close | 2.1700 |
Open | 2.3000 |
Bid | 2.3100 |
Ask | 2.6900 |
Strike | 52.50 |
Expire Date | 2026-01-16 |
Day's Range | 2.3000 - 2.6700 |
Contract Range | N/A |
Volume | |
Open Interest | 788 |
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....